top line progress cost busi rise
view colgat make progress improv organ growth
encourag return volum growth manag make
right decis increas advertis see earli return
invest though concern requir given
increas competit space see limit upsid potenti
year ep given dynam reiter sp
takeaway quarter posit volum acceler
volum growth cl strongest deliveri three year
acceler larg led improv hill
modest improv emerg market well includ apac
posit first time six quarter latin america
encourag respons cl see volum increas
market invest note compani still way go
close growth gap peer return share gain hill strong
quarter organ basi benefit scienc diet
roll-out global strong growth us neg gross margin
cl outlook gross margin revis year due
varieti factor cl call increas mix headwind due faster
grow emerg market growth scienc diet hill
lower margin cl also note commod bigger
headwind expect contrast heard
cpg player quarter ebit miss organ sale
stronger ebit notic miss rel consensu
gross margin higher expect sg
guidanc thought cl guidanc larg unchang
except gross margin headwind cite seem achiev
year believ cl make good progress organ sale
still need improv trend consum product sustain
turnaround expect cl step spend behind
brand next year organ sale growth slow benefit
scienc diet roll-out subsid cl goe tougher compar
expect cl return hsd growth algorithm next year
adjust estim adjust estim slightli
account lower expect gross margin
off-set flow chang tax rate rais
estim lower ep
estim account lower gross margin outlook flat vs slightli
previous increas market spend vs flat previous
slowdown organ growth tougher compar
year lower ep yoy
valu usd unless otherwis note
price prior trade day market close estimate unless otherwis note
sale deceler amid macro volatil heighten
competit global particularli emerg market
latin america account colgat profit
commod cost fx also add uncertainti stori
expans global growth effici program
initi compani expect achiev annual
save expect three-
four-year cash payback averag after-tax rate
return greater given compani execut track
record confid like abl come
high end target
continu macro headwind latin america
colgat gener profit declin
emerg market
currenc could materi impact compani top
line profit increas competit activ
oral care colgat core market especi could
hinder organ sale growth share gain
bloomberg capit market estim upside/downside/target
dcf-driven base case scenario valu cl share
assum top-lin compound-annual-growth-rate peak profit margin
valu colgat assum wacc
long run termin growth rate
dcf-driven upsid scenario valu cl share
upsid case assum top-lin compound-annual-growth-rate peak
profit margin scenario colgat
regain share behind new innov along whitespac
expans upsid compani announc cost
save valu colgat upsid case assum wacc
long run termin growth rate
dcf-driven downsid scenario valu cl share
downsid case assum top-lin compound-annual-growth-rate
peak profit margin
scenario colgat face stepped-up competit
competitor emerg market unabl meet cost-
save expect valu colgat downsid case
assum wacc long run termin growth
rate
dcf-driven base case scenario valu cl share assum top-lin compound-annual-growth-rate
peak profit margin valu colgat assum wacc
long run termin growth rate price target support sector perform
risk rate price target
volatil emerg market currenc could materi impact compani
top line profit estim colgat currenc exposur select currenc
brazilian real euro mexican peso venezuelan bolivar australian
dollar british pound
volatil input cost includ supplier cost raw packag materi commod
resin tropic oil essenti oil tallow poultri corn soybean subject
wide price variat increas cost avail commod
cost energi transport necessari servic may advers affect
profit margin compani unabl pass along higher cost form price
increas otherwis achiev cost effici manufactur distribut
increas competit activ oral care colgat core market especi
could hinder organ sale growth share gain respond competit activ often
take manag time increment expens price reduct
colgate-palmol manufactur oral care person care home care product
global oral care offer includ toothpast toothbrush mouth wash dental floss
pharmaceut product primarili compani colgat brand person
care segment compani sell hand bodi soap shower gel deodor hair care
product variou brand includ palmol irish spring home care segment
compris laundri dishwash deterg household cleaner palmol
ajax brand compani also market pet food hill segment hill
scienc diet brand name compani found headquart new
ms except ep ratio
good sold
net incom attribut cl
sourc capit market estim compani document
